Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion type Assertion NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_head.
- NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion wasGeneratedBy ECO_0000203 NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_provenance.
- NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion wasDerivedFrom befree-20140225 NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_provenance.
- NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion SIO_000772 19960344 NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_provenance.
- NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion evidence source_evidence_literature NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_provenance.
- NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_assertion description "[To evaluate the effect of excision repair cross-complementing group 1 (ERCC1) and X-ray cross-complementing group 1 (XRCC1) gene polymorphisms on treatment outcome in patients receiving oxaliplatin-based regimens for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486501.RAScDbJW6SP56TeD-1fesIJHhdPl3-zMVNKPvMblkNdAE130_provenance.